메뉴 건너뛰기




Volumn 168, Issue 3, 2013, Pages 2588-2592

Incidence and predictors of the late catch-up phenomenon after drug-eluting stent implantation

Author keywords

Drug eluting stent; Late catch up phenomenon; Late in stent restenosis; Percutaneous coronary intervention; Very late stent thrombosis

Indexed keywords

HEPARIN; PACLITAXEL; RAPAMYCIN;

EID: 84885660435     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.03.046     Document Type: Article
Times cited : (30)

References (16)
  • 1
    • 0032555180 scopus 로고    scopus 로고
    • Neointimal tissue response at sites of coronary stenting in humans: Macroscopic, histological, and immunohistochemical analyses
    • R. Komatsu, M. Ueda, T. Naruko, A. Kojima, and A.E. Becker Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses Circulation 98 1998 224 233
    • (1998) Circulation , vol.98 , pp. 224-233
    • Komatsu, R.1    Ueda, M.2    Naruko, T.3    Kojima, A.4    Becker, A.E.5
  • 2
    • 13344293686 scopus 로고    scopus 로고
    • Three-year follow-up after implantation of metallic coronary-artery stents
    • T. Kimura, H. Yokoi, and Y. Nakagawa Three-year follow-up after implantation of metallic coronary-artery stents N Engl J Med 334 1996 561 566
    • (1996) N Engl J Med , vol.334 , pp. 561-566
    • Kimura, T.1    Yokoi, H.2    Nakagawa, Y.3
  • 3
    • 33847766568 scopus 로고    scopus 로고
    • Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents
    • A. Kastrati, J. Mehilli, and J. Pache Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 2007 1030 1039
    • (2007) N Engl J Med , vol.356 , pp. 1030-1039
    • Kastrati, A.1    Mehilli, J.2    Pache, J.3
  • 4
    • 24644465504 scopus 로고    scopus 로고
    • Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent
    • R. Wessely, A. Kastrati, and A. Schömig Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent Ann Intern Med 143 2005 392 394
    • (2005) Ann Intern Med , vol.143 , pp. 392-394
    • Wessely, R.1    Kastrati, A.2    Schömig, A.3
  • 5
    • 33748079468 scopus 로고    scopus 로고
    • Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials)
    • T.T. Lee, L. Feinberg, and D.S. Baim Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials) Am J Cardiol 98 2006 718 721
    • (2006) Am J Cardiol , vol.98 , pp. 718-721
    • Lee, T.T.1    Feinberg, L.2    Baim, D.S.3
  • 7
    • 34548851431 scopus 로고    scopus 로고
    • Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era
    • R. Iijima, G. Ndrepepa, and J. Mehilli Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era Am Heart J 154 2007 688 693
    • (2007) Am Heart J , vol.154 , pp. 688-693
    • Iijima, R.1    Ndrepepa, G.2    Mehilli, J.3
  • 8
    • 33847167065 scopus 로고    scopus 로고
    • Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study
    • J. Daemen, P. Wenaweser, and K. Tsuchida Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678
    • (2007) Lancet , vol.369 , pp. 667-678
    • Daemen, J.1    Wenaweser, P.2    Tsuchida, K.3
  • 9
    • 39849098745 scopus 로고    scopus 로고
    • ESTROFA Study Group. Drug-eluting stent thrombosis: Results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos)
    • J.M. de la Torre-Hernández, F. Alfonso, and F. Hernández ESTROFA Study Group. Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos) J Am Coll Cardiol 51 2008 986 990
    • (2008) J Am Coll Cardiol , vol.51 , pp. 986-990
    • De La Torre-Hernández, J.M.1    Alfonso, F.2    Hernández, F.3
  • 10
    • 70349896556 scopus 로고    scopus 로고
    • Stent thrombosis after drug-eluting stent implantation: Incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period
    • S. Schulz, T. Schuster, and J. Mehilli Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period Eur Heart J 30 2009 2714 2721
    • (2009) Eur Heart J , vol.30 , pp. 2714-2721
    • Schulz, S.1    Schuster, T.2    Mehilli, J.3
  • 11
    • 64749101214 scopus 로고    scopus 로고
    • Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer
    • R.A. Byrne, R. Iijima, and J. Mehilli Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer JACC Cardiovasc Interv 2 2009 291 299
    • (2009) JACC Cardiovasc Interv , vol.2 , pp. 291-299
    • Byrne, R.A.1    Iijima, R.2    Mehilli, J.3
  • 12
    • 77955469156 scopus 로고    scopus 로고
    • J-Cypher Registry Investigators. Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry)
    • Y. Nakagawa, T. Kimura, and T. Morimoto j-Cypher Registry Investigators. Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry) Am J Cardiol 106 2010 329 336
    • (2010) Am J Cardiol , vol.106 , pp. 329-336
    • Nakagawa, Y.1    Kimura, T.2    Morimoto, T.3
  • 14
    • 10744229988 scopus 로고    scopus 로고
    • Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious?
    • R. Virmani, G. Guagliumi, and A. Farb Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109 2004 701 705
    • (2004) Circulation , vol.109 , pp. 701-705
    • Virmani, R.1    Guagliumi, G.2    Farb, A.3
  • 15
    • 79952414020 scopus 로고    scopus 로고
    • The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents
    • G. Nakazawa, F. Otsuka, and M. Nakano The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents J Am Coll Cardiol 57 2011 1314 1322
    • (2011) J Am Coll Cardiol , vol.57 , pp. 1314-1322
    • Nakazawa, G.1    Otsuka, F.2    Nakano, M.3
  • 16
    • 84861371093 scopus 로고    scopus 로고
    • Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: A pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials
    • G.G. Stefanini, R.A. Byrne, and P.W. Serruys Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials Eur Heart J 33 2012 1214 1222
    • (2012) Eur Heart J , vol.33 , pp. 1214-1222
    • Stefanini, G.G.1    Byrne, R.A.2    Serruys, P.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.